Free Cash Flow Build Up

Satsuma Pharmaceuticals, Inc. (STSA)

$5.79

-0.17 (-2.85%)
Year
A/P
Revenue
EBITDA
EBIT
Tax Rate
EBIAT
Depreciation
Accounts Receivable
Inventories
Accounts Payable
Capital Expenditure
UFCF
WACC
PV UFCF
SUM PV UFCF